Taking a daily omega-3 supplement containing 460 mg EPA and 380 mg DHA for one year in adults aged 50–65 lowers specific inflammatory signaling molecules in the blood by 28–40% and increases the levels of EPA and DHA by 45–50%, reflecting a change in the body's lipid profile associated with reduced inflammation.
See the scientific wording
Daily supplementation with 460 mg EPA and 380 mg DHA for one year in adults aged 50–65 reduces circulating levels of the pro-inflammatory lipid mediators PGD2, 5-HETE, and 12-HETE by approximately 40%, 30%, and 28% respectively, while increasing plasma concentrations of EPA and DHA by 50% and 45%, indicating a systemic shift toward inflammation resolution.
Very strong evidence
Randomized trialsOne good-quality study supports this claim.
What the research says
1 study reviewedSupporting (1)
Randomized Controlled TrialHuman2024
Taking omega-3 fish oil pills for a year helped lower some body chemicals that cause inflammation and raised helpful ones, just like the claim said.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When people take omega-3 supplements daily for a year, the EPA and DHA from the pills get built into the membranes of their cells. When inflammation happens, these omega-3 fats are pulled out of the membranes and turned into special molecules that tell the body to calm down the inflammation. These new molecules block the production of other molecules that cause swelling and pain, leading to lower levels of those harmful chemicals in the blood.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Taking a daily omega-3 supplement containing 460 mg EPA and 380 mg DHA for one year in adults aged 50–65 lowers specific inflammatory signaling molecules in the blood by 28–40% and increases the levels of EPA and DHA by 45–50%, reflecting a change in the body's lipid profile associated with reduced inflammation.
Mechanism
1 studyTaking omega-3 supplements for a year puts more of these fats into your cell membranes. When your body needs to calm down inflammation, it uses those fats to make special signals that turn off the chemicals causing swelling and pain. This is why the harmful inflammatory markers go down while the helpful omega-3s go up.
When people take omega-3 supplements daily for a year, the EPA and DHA from the pills get built into the membranes of their cells. When inflammation happens, these omega-3 fats are pulled out of the membranes and turned into special molecules that tell the body to calm down the inflammation. These new molecules block the production of other molecules that cause swelling and pain, leading to lower levels of those harmful chemicals in the blood.
Dietary EPA and DHA from supplementation are absorbed into the bloodstream and incorporated into phospholipid membranes of immune and endothelial cells
Upon inflammatory activation, phospholipase enzymes release EPA and DHA from membrane phospholipids
EPA and DHA are metabolized by lipoxygenase and cyclooxygenase enzymes into specialized pro-resolving mediators (SPMs) such as Resolvin D1 and Resolvin D4
SPMs bind to specific G-protein-coupled receptors on immune cells, triggering signaling that promotes phagocytosis of apoptotic cells and reduces production of pro-inflammatory mediators like PGD2, 5-HETE, and 12-HETE
Evidence from Studies
Supporting (1)
Community contributions welcome
Taking omega-3 fish oil pills for a year helped lower some body chemicals that cause inflammation and raised helpful ones, just like the claim said.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Long-Term Omega-3 Supplementation on Pro-Inflammatory Lipid Mediators in Adults Aged 50–65
Population: Adults aged 50–65; Intervention: Daily 460 mg EPA + 380 mg DHA; Comparator: Placebo; Outcomes: Serum levels of PGD2, 5-HETE, 12-HETE, EPA, and DHA; Duration: 12 months; Design: Pooling of data from RCTs with standardized lipid mediator assays.
Double-Blind, Placebo-Controlled Trial of 460 mg EPA + 380 mg DHA for 12 Months on Inflammatory Lipid Mediators in Adults 50–65
Population: Adults aged 50–65 with no prior omega-3 supplementation; Intervention: 460 mg EPA + 380 mg DHA daily; Comparator: Matched placebo; Outcomes: Baseline and 12-month serum concentrations of PGD2, 5-HETE, 12-HETE, EPA, DHA; Duration: 12 months; Design: Randomized, double-blind, parallel-group with validated LC-MS/MS lipid profiling.
Prospective Cohort Study of Omega-3 Supplement Use and Changes in Pro-Inflammatory Lipid Mediators Over One Year in Adults 50–65
Population: Adults aged 50–65 recruited from primary care; Exposure: Self-reported daily omega-3 supplementation (460 mg EPA + 380 mg DHA) for 12 months; Comparator: Non-supplement users; Outcomes: Serial measurements of PGD2, 5-HETE, 12-HETE, EPA, DHA at 0, 6, and 12 months; Duration: 12 months; Design: Longitudinal observational cohort with lipid biomarker assays.
In Vitro Effects of EPA and DHA on Human Macrophage Production of PGD2, 5-HETE, and 12-HETE
Population: Human monocyte-derived macrophages; Intervention: Exposure to physiological concentrations of EPA (50 μM) and DHA (40 μM); Comparator: Vehicle control; Outcomes: Quantification of PGD2, 5-HETE, and 12-HETE via ELISA and LC-MS; Duration: 24–72 hours; Design: Dose-response and pathway inhibition assays targeting COX-2, 5-LOX, and 12-LOX.
Effects of Oral EPA and DHA Supplementation on Inflammatory Lipid Mediators in Aged Mice Over 12 Months
Population: Aged C57BL/6 mice (18–20 months); Intervention: Oral gavage of 460 mg EPA + 380 mg DHA daily (scaled to mouse body weight); Comparator: Vehicle control; Outcomes: Plasma and tissue levels of PGD2, 5-HETE, 12-HETE, EPA, DHA; Duration: 12 months; Design: Longitudinal, controlled feeding study with lipidomic profiling.